Vaishali Pharma Ltd. | Small-cap | Healthcare
₹11.86
-2.06%
| Vaishali Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 817.6M
Gross Profit 73.5M 8.99%
Operating Income 63.4M 7.75%
Net Income 7.2M 0.88%
EPS (Diluted) ₹0.06

Balance Sheet Metrics

Total Assets 799.6M
Total Liabilities 371.2M
Shareholders Equity 428.4M
Debt to Equity 0.87

Cash Flow Metrics

Operating Cash Flow 37.2M
Free Cash Flow 7.0M

Revenue & Profitability Trend

Vaishali Pharma Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 817.6M 638.2M 715.4M 523.1M 584.1M
Cost of Goods Sold 744.2M 546.8M 635.0M 461.5M 510.9M
Gross Profit 73.5M 91.5M 80.4M 61.6M 73.2M
Operating Expenses 26.9M 34.3M 32.5M 12.8M 19.3M
Operating Income 63.4M 89.7M 64.8M 40.4M 46.3M
Pre-tax Income 9.3M 88.5M 57.3M 14.0M 791.1K
Income Tax 2.1M 22.4M 17.0M 3.6M 463.2K
Net Income 7.2M 66.0M 40.2M 10.5M 327.8K
EPS (Diluted) ₹0.06 ₹0.59 ₹0.38 ₹0.10 ₹0.00

Income Statement Trend

Vaishali Pharma Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 745.2M 726.7M 764.3M 813.0M 613.1M
Non-Current Assets 54.4M 62.3M 52.0M 48.3M 49.0M
Total Assets 799.6M 789.0M 816.2M 861.3M 662.0M
Liabilities
Current Liabilities 330.8M 320.7M 519.4M 592.6M 404.2M
Non-Current Liabilities 40.3M 63.0M 33.3M 44.4M 44.1M
Total Liabilities 371.2M 383.7M 552.7M 637.1M 448.2M
Equity
Total Shareholders Equity 428.4M 405.3M 263.5M 224.2M 213.8M

Balance Sheet Composition

Vaishali Pharma Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 9.3M 88.5M 57.3M 14.0M 791.1K
Operating Cash Flow 37.2M 135.0M 139.8M -176.2M 15.9M
Investing Activities
Capital Expenditures -1.1M -3.0M -8.6M -1.3M -526.0K
Investing Cash Flow -1.1M -3.0M -8.6M -1.3M -526.0K
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 18.5M -17.3M 49.7M -13.1K 1.4M
Free Cash Flow 7.0M 7.8M 4.5M 18.9M 31.7M

Cash Flow Trend

Vaishali Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 214.50
Price to Book 2.33
Price to Sales 1.59
PEG Ratio -2.41

Profitability Ratios

Profit Margin 0.43%
Operating Margin 4.46%
Return on Equity 1.68%
Return on Assets 0.90%

Financial Health

Current Ratio 2.98
Debt to Equity 19.36
Beta 0.30

Per Share Data

EPS (TTM) -₹1.55
Book Value per Share ₹5.20
Revenue per Share ₹26.28

Financial data is updated regularly. All figures are in the company's reporting currency.